Contraline Executes Global Exclusive License Agreement for NES/T Male Contraceptive Gel

Contraline & Population Council Announce Option-to-License Agreement for a Revolutionary Male Contraceptive

Contraline’s First In-Human Trial Shows Safety with 12-Month Efficacy Signals of the ADAM™ Male Contraceptive Device

DNA Diagnostics Center Partners with Contraline in ADAMTM Clinical Trial, Testing Revolutionary Male Contraceptive

Kevin Eisenfrats is developing the ‘male IUD’

A Gel Injected Into the Scrotum Could Be the Next Male Contraceptive